{"transactions":[{"id":4628872,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-10-02T22:14:09.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":false,"shares":614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":7984,"derivative":{"underlying":"Common Stock","underlying_shares":614},"source":{"system":"sec-edgar","filing":"0001437749-26-031924","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1892297/000143774926031924/rdgdoc.xml","form_type":"4"}},{"id":4628871,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-02T22:14:09.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":180,"price":79.67,"value":14340.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units."}],"balance_after":2655,"source":{"system":"sec-edgar","filing":"0001437749-26-031924","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1892297/000143774926031924/rdgdoc.xml","form_type":"4"}},{"id":4628870,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-02T22:14:09.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":true,"shares":614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":2835,"source":{"system":"sec-edgar","filing":"0001437749-26-031924","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892297/000143774926031924/rdgdoc.xml","form_type":"4"}},{"id":717148,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-07-02T23:38:27.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":1228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":8598,"derivative":{"underlying":"Common Stock","underlying_shares":1228},"source":{"system":"sec-edgar","filing":"0001437749-26-022631","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774926022631/rdgdoc.xml","form_type":"4"}},{"id":717147,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T23:38:27.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":507,"price":92.59,"value":46943.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units."}],"balance_after":2221,"source":{"system":"sec-edgar","filing":"0001437749-26-022631","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774926022631/rdgdoc.xml","form_type":"4"}},{"id":717146,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T23:38:27.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":1228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":2728,"source":{"system":"sec-edgar","filing":"0001437749-26-022631","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774926022631/rdgdoc.xml","form_type":"4"}},{"id":957885,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T17:15:31.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":69.95,"value":104925.0,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001437749-25-038804","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925038804/rdgdoc.xml","form_type":"4"}},{"id":977293,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-08T21:47:01.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":9826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter."}],"balance_after":9826,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9826},"source":{"system":"sec-edgar","filing":"0001437749-25-037164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925037164/rdgdoc.xml","form_type":"4"}},{"id":977292,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-12-08T21:47:01.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":7135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter."}],"balance_after":7135,"derivative":{"exercise_price":75.94,"expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":7135},"source":{"system":"sec-edgar","filing":"0001437749-25-037164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925037164/rdgdoc.xml","form_type":"4"}},{"id":1221571,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-03-05T21:06:54.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 3, 2025, the reporting person was granted 25,000 stock options, vesting 6/48ths (15,625 shares) on September 2, 2025, and 1/48th every month thereafter until the stock option is fully vested on March 3, 2029."}],"balance_after":25000,"derivative":{"exercise_price":30.93,"expiration_date":"2035-03-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-006297","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925006297/rdgdoc.xml","form_type":"4"}},{"id":2469916,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO / Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-12-16T22:00:10.000Z","date":"2021-12-16","kind":"purchase","acquired":true,"shares":8000,"price":3.98,"value":31840.0,"ownership":{"direct":true},"balance_after":20500,"source":{"system":"sec-edgar","filing":"0001213900-21-065725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021065725/ownership.xml","form_type":"4"}},{"id":2477278,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO / Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-12-10T23:04:31.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":4500,"price":3.9,"value":17550.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001213900-21-064763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021064763/ownership.xml","form_type":"4"}},{"id":2477275,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":32622,"kind":"person","name":"Vu Quan Anh","position":1,"cik":"0001892297","reported_name":"Vu Quan Anh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO / Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T13:20:48.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as COO / Chief Business Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in 48 equal monthly installments, beginning on the last day of November 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates."}],"balance_after":275000,"derivative":{"exercise_price":3.95,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001213900-21-064568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021064568/ownership.xml","form_type":"4"}}]}